Advances in understanding the genetic basis for bone-marrow failure

Current Opinion in Pediatrics

Volumn 18, Issue 1, 2006, Pages 15-21

  Lieberman, Lani ^a   Dror, Yigal ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Aplastic anemia; Genetics; Inherited marrow failure syndromes; Myelodysplasia

Indexed keywords

DYSKERIN; GROWTH FACTOR; ELAC2 PROTEIN, HUMAN; RNA; TELOMERASE; TELOMERASE RNA; TUMOR PROTEIN;

BIOGENESIS; BLACKFAN DIAMOND ANEMIA; BONE MARROW DEPRESSION; CANCER GENETICS; CELL SURVIVAL; CLINICAL PRACTICE; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DNA REPAIR; DYSKERATOSIS; FANCONI ANEMIA; FERTILIZATION IN VITRO; GENE IDENTIFICATION; GENE THERAPY; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOMOZYGOSITY; HUMAN; KOSTMANN SYNDROME; PATHOGENESIS; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RIBOSOME; RNA METABOLISM; SHWACHMAN SYNDROME; SIGNAL TRANSDUCTION; TELOMERE; THROMBOCYTOPENIA; BONE MARROW; HEMATOLOGIC DISEASE; PATHOPHYSIOLOGY;

ANEMIA, DIAMOND-BLACKFAN; BONE MARROW; FANCONI ANEMIA; HEMATOLOGIC DISEASES; HUMANS; NEOPLASM PROTEINS; RNA; TELOMERASE; THROMBOCYTOPENIA;

EID: 33646948760     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mop.0000192520.48411.fa     Document Type: Review

References (93)

1. Steele JM, Klaassan R, Fernandez C, et al. Disease progression in recently diagnosed patients with inherited marrow failure syndromes: a report from the Canadian Inherited Marrow Failure Registry (CIMFR). Cancer Blood 2005; 44:538.
2. Kutler DI, Singh B, Satagopan J, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 2003; 101:1249-1256.
3. Alter BP. Cancer in Fanconi anemia, 1927-2001. Cancer 2003; 97:425-440.
4. Lo TF Jr,, Rooimans MA, Bosnoyan-Collins L, et al. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat Genet 1996; 14:320-323.
5. Meetei AR, Levitus M, Xue Y, et al. X-linked inheritance of Fanconi anemia complementation group B. Nat Genet 2004; 36:1219-1224. In this article the first X-linked Fanconi-anemia gene was identified. This report not only attests to the complexity of the biology of the disorder, but also to the complexity of genetic counseling, which was thought to be simpler before.
6. Strathdee CA, Duncan AM, Buchwald M. Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nat Genet 1992; 1: 196-198.
7. Howlett NG, Taniguchi T, Olson S, et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002; 297:606-609.
8. Timmers C, Taniguchi T, Hejna J, et al. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell 2001; 7:241-248.
9. De Winter JP, Leveille F, van Berkel CG, et al. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am J Hum Genet 2000; 67:1306-1308.
10. De Winter JP, Rooimans MA, van Der WL, et al. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat Genet 2000; 24:15-16.
11. De Winter JP, Waisfisz Q, Rooimans MA, et al. The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat Genet 1998; 20:281-283.
12. Levitus M, Rooimans MA, Steltenpool J, et al. Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes. Blood 2004; 103:2498-2503. This work adds two new Fanconi-anemia genes to the list of genes associated with this complex disorder.
13. Meetei AR, de Winter JP, Medhurst AL, et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet 2003; 35:165-170.
14. Meetei AR, Medhurst AL, Ling C, et al. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat Genet 2005; 37:958-963. This work adds a new Fanconi anemia gene to the list of genes associated with this complex disorder, which further links the disorder with abnormalities in DNA repair.
15. Boocock GR, Morrison JA, Popovic M, et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet 2003; 33:97-101.
16. Heiss NS, Knight SW, Vulliamy TJ, et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 1998; 19:32-38.
17. Vulliamy T, Marrone A, Goldman F, et al. The RNA component of telomerase mutated in autosomal dominated dyskeratosis congenita. Nature 2001; 413: 432-435.
18. Tonelli R, Scardovi AL, Pession A, et al. Compound heterozygosity for two different amino-acid substitution mutations in the thrombopoietin receptor (c-mpl gene) in congenital amegakaryocytic thrombocytopenia (CAMT). Hum Genet 2000; 107:225-233.
19. Rotig A, Cormier V, Blanche S, et al. Pearson's marrow-pancreas syndrome: a multisystem mitochondrial disorder in infancy. J Clin Invest 1990; 86: 1601-1608.
20. Draptchinskaia N, Gustavsson P, Andersson B, et al. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet 1999; 21:169-175.
21. Cotter PD, Baumann M, Bishop DF. Enzymatic defect in 'X-linked' sideroblastic anemia: molecular evidence for erythroid delta-aminolevulinate synthase deficiency. Proc Natl Acad Sci U S A 1992; 89:4028-4032.
22. Allikmets R, Raskind WH, Hutchinson A, et al. Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A). Hum Mol Genet 1999; 8:743-749.
23. Fleming JC, Tartaglini E, Steinkamp MP, et al. The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter. Nat Genet 1999; 22:305-308.
24. Dgany O, Avidan N, Delaunay J, et al. Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1. Am J Hum Genet 2002; 71: 1467-1474.
25. Dale DC, Person RE, Bolyard AA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000; 96:2317-2322.
26. Person RE, Li FQ, Duan Z, et al. Mutations in proto-oncogene GFM cause human neutropenia and target ELA2. Nat Genet 2003; 34:308-312.
27. Devriendt K, Kim AS, Mathijs G, et al. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet 2001; 27:313-317.
28. Horowitz M, Benson K, Person RE, et al. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet 1999; 23:433-436.
29. Hernandez PA, Gorlin RJ, Lukens JN, et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 2003; 34:70-74.
30. Annabi B, Hiraiwa H, Mansfield BC, et al. The gene for glycogen-storage disease type 1b maps to chromosome 11q23. Am J Hum Genet 1998; 62: 400-405.
31. Bione S, D'Adamo P, Maestrini E, et al. A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat Genet 1996; 12:385-389.
32. Seri M, Pecci A, Di Bari F, et al. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine 2003; 82:203-215.
33. Gandhi MJ, Cummings CL, Drachman JG. FLJ14813 missense mutation: a candidate for autosomal dominant thrombocytopenia on human chromosome 10. Hum Hered 2003; 55:66-70.
34. Nichols KE, Crispino JD, Poncz M, et al. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat Genet 2000; 24:266-270.
35. Song WJ, Sullivan MG, Legare RD, et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 1999; 23:166-175.
36. Thompson AA, Nguyen LT. Amegakaryocytic thrombocytopenia and radio-ulnar synostosis are associated with HOXA11 mutation. Nat Genet 2000; 26:397-398.
37. Dror Y. Inherited marrow failure syndromes. In Pediatric Hematology, 3rd ed. Blackwell, Oxford, UK (in press).
38. Yoshida MC. Suppression of spontaneous and mitomycin C-induced chromosome aberrations in Fanconi's anemia by cell fusion with normal human fibroblasts. Hum Genet 1980; 55:223-226.
39. Duckworth-Rysiecki G, Cornish K, Clarke CA, Buchwald M. Identification of two complementation groups in Fanconi anemia. Somat Cell Mol Genet 1985; 11:35-41.
40. Faivre L, Guardiola P, Lewis C, et al. Association of complementation group and mutation type with clinical outcome in Fanconi anemia. European Fanconi Anemia Research Group. Blood 2000; 96:4064-4070.
41. Gillio AP, Verlander PC, Batish SD, et al. Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an International Fanconi Anemia Registry study. Blood 1997; 90:105-110.
42. Futaki M, Yamashita T, Yagasaki H, et al. The IVS4 + 4 A to T mutation of the Fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients. Blood 2000; 95:1493-1498.
43. Verlander PC, Lin JD, Udono MU, et al. Mutation analysis of the Fanconi anemia gene FACC. Am J Hum Genet 1994; 54:595-601.
44. Rathbun RK, Christianson TA, Faulkner GR, et al. Interferon-gamma-induced apoptotic responses of Fanconi anemia group C hematopoietic progenitor cells involve caspase 8-dependent activation of caspase 3 family members. Blood 2000; 96:4204-4211.
45. Cumming RC, Lightfoot J, Beard K, et al. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nat Med 2001; 7:814-820.
46. Pang Q, Keeble W, Christianson TA, et al. FANCC interacts with Hsp70 to protect hematopoietic cells from IFN-gamma/TNF-alpha-mediated cytotoxicity. EMBO J 2001; 20:4478-4489.
47. Shihab-el-Deen A, Guevara C, Prchal JF. Bone marrow cultures in dysmyelopoietic syndrome: diagnostic and prognostic evaluation. Acta Haematol 1987; 78:17-22.
48. Levran O, Diotti R, Pujara K, et al. Spectrum of sequence variations in the FANCA gene: an International Fanconi Anemia Registry (IFAR) study. Hum Mutat 2005; 25:142-149.
49. Walsh CE, Grompe M, Vanin E, et al. A functionally active retrovirus vector for gene therapy in Fanconi anemia group C. Blood 1994; 84:453-459.
50. Walsh C. Gene therapy for group A Fanconi anemia patients: current update and future trials. Fanconi Anemia Sc Lett 2001; 30:9.
51. Verlinsky Y, Rechitsky S, Schoolcraft W, et al. Preimplantation diagnosis for Fanconi anemia combined with HLA matching. JAMA 2001; 285:3130-3133.
52. Bielorai B, Hughes MR, Auerbach AD, et al. Successful umbilical cord blood transplantation for Fanconi anemia using preimplantation genetic diagnosis for HLA-matched donor. Am J Hematol 2004; 77:397-399.
53. Aggett PJ, Cavanagh NP, Matthew DJ, et al. Shwachman's syndrome a review of 21 cases. Arch Dis Child 1980; 55:331-347.
54. Shwachman H, Diamond LK, Oski FA, Khaw K-T. The syndrome of pancreatic insufficiency and bone marrow dysfunction. J Pediatr 1964; 65:645-663.
55. Bodian M, Sheldon W, Lightwood R. Congenital hypoplasia of the exocrine pancreas. Acta Paediatr 1964; 53:282-293.
56. Lai CH, Chou CY, Ch'ang LY, et al. Identification of novel human genes evolutionarily conserved in Caenorhabditis elegans by comparative proteomics. Genome Res 2000; 10:703-713.
57. Woloszynek JR, Rothbaum RJ, Rawls AS, et al. Mutations of the SBDS gene are present in most patients with Shwachman-Diamond syndrome. Blood 2004; 104:3588-3590. Shows that most patients have SBDS mutations and reduced Sbds protein.
58. Kuijpers TW, Alders M, Tool AT, et al. Hematologic abnormalities in Shwachman Diamond syndrome: lack of genotype-phenotype relationship. Blood 2005; 106:356-361. Shows that SDS patients with the common SBDS mutations can have varied phenotype.
59. Makitie O, Ellis L, Durie PR, et al. Skeletal phenotype in patients with Shwachman-Diamond syndrome and mutations in SBDS. Clin Genet 2004; 65:101-112.
60. Majeed F, Jadk S, Freedman M, Dror Y. Mutation analysis of SBDS in pediatric acute myeloblastic leukemia with and without chromosome 7 abnormalities. 2005; 45:920-924. Demonstrates no role of SBDS gene mutations in childhood de-novo AML.
61. Dror Y, Freedman MH. Shwachman-Diamond syndrome is an inherited preleukemic bone marrow failure disorder with aberrant hematologi progenitors and faulty marrow microenvironment. Blood 1999; 94:3048-3054.
62. Dror Y, Freedman MH. Shwachman-Diamond syndrome marrow cells show abnormally increased apoptosis mediated through the Fas pathway. Blood 2001; 97:3011-3016.
63. Thornley I, Dror Y, Sung L, et al. Abnormal telomere shortening in leucocytes of children with Shwachman-Diamond syndrome. Br J Haematol 2002; 117: 189-192.
64. Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol 2000; 110: 768-779.
65. Zinnsser F. Atrophia cutis reticularis cum pigmentatione, dystrophia unguium et leukoplakia oris. lkonogr Dermatol (Hyoto) 1906; 5:219-223.
66. Engmann MF. A unique case of reticular pigmentation of the skin with atrophy. Arch Dermatol Syphiligraph 1926; 133:685-687.
67. Vulliamy TJ, Knight SW, Mason PJ, Dokal I. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol Dis 2001; 27:353-357.
68. Dokal I, Bungey J, Williamson P, et al. Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements. Blood 1992; 80:3090-3096.
69. Dokal I, Luzzatto L. Dyskeratosis congenita is a chromosomal instability disorder. Leuk Lymphoma 1994; 15:1-7.
70. Alter BP. Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Ginsberg D, Look AT, editors. Hematology of infancy and childhood. Philadelphia: W.B. Saunders; 2003. pp. 280-365.
71. King S, Germeshausen M, Strauss G, et al. Congenital anegakaryocytic thrombocytopenia (CAMT): a detailed clinical analysis of 21 cases reveals different types of CAMT. Blood 2004; 104:740A.
72. Muraoka K, Ishii E, Tsuji K, et al. Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia. Br J Haematol 1997; 96:287-292.
73. van den Oudenrijn S, Bruin M, Folman CC, et al. Three parameters, plasma thrombopoietin levels, plasma glycocalicin levels and megakaryocyte culture, distinguish between different causes of congenital thrombocytopenia. Br J Haematol 2002; 117:390-398.
74. Ballmaier M, Germeshausen M, Krukemeier S, Welte K. Thrombopoietin is essential for the maintenance of normal hematopoiesis in humans: development of aplastic anemia in patients with congenital amegakaryocytic thrombocytopenia. Ann N Y Acad Sci 2003; 996:17-25.
75. Diamond LK, Blackfan KD. Hypoplastic anemia. Am J Dis Child 1938; 56: 464-467.
76. Halperin DS, Freedman MH. Diamond-Blackfan anemia: etiology, pathophysiology, and treatment. Am J Pediatr Hematol Oncol 1989; 11:380-394.
77. Glader BE, Backer K. Elevated red cell adenosine deaminase activity: a marker of disordered erythropoiesis in Diamond-Blackfan anaemia and other haematologic diseases. Br J Haematol 1988; 68:165-168.
78. Willig TN, Draptchinskaia N, Dianzani I, et al. Mutations in ribosomal protein S19 gene and Diamond Blackfan anemia: wide variations in phenotypic expression. Blood 1999; 94:4294-4306.
79. Gustavsson P, Skeppner G, Johansson B, et al. Diamond-Blackfan anaemia in a girl with a de novo balanced reciprocal X;19 translocation. J Med Genet 1997; 34:779-782.
80. Da Costa L, Tchernia G, Gascard P, et al. Nucleolar localization of RPS19 protein in normal cells and mislocalization due to mutations in the nucleolar localization signals in 2 Diamond-Blackfan anemia patients: potential insights into pathophysiology. Blood 2003; 101:5039-5045.
81. Da Costa L, Narla G, Willig TN, et al. Ribosomal protein S19 expression during erythroid differentiation. Blood 2003; 101:318-324.
82. Hamaguchi I, Ooka A, Brun A, et al. Gene transfer improves erythroid development in ribosomal protein S19-deficient Diamond-Blackfan anemia. Blood 2002; 100:2724-2731.
83. Perdahl EB, Naprstek BL, Wallace WC, Lipton JM. Erythroid failure in Diamond-Blackfan anemia is characterized by apoptosis. Blood 1994; 83: 645-650.
84. Miyake K, Flygare J, Kiefer T, et al. Development of cellular models for ribosomal protein S19 (RPS19)-deficient Diamond-Blackfan anemia using inducible expression of siRNA against RPS19. Mol Ther 2005; 11:627-637. Demonstrates that hematopoietic progenitor cells inhibited by siRNA have reduced erythroid differentiation, cell growth and colony formation.
85. Ancliff PJ, Gale RE, Liesner R, et al. Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease. Blood 2001; 98:2645-2650.
86. Dong F, Brynes RK, Tidow N, et al. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med 1995; 333: 487-493.
87. Fouret P, du Bois RM, Bernaudin JF, et al. Expression of the neutrophil elastase gene during human bone marrow cell differentiation. J Exp Med 1989; 169:833-845.
88. Cowland JB, Borregaard N. The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules. J Leukoc Biol 1999; 66:989-995.
89. Benson KF, Li FQ, Person RE, et al. Mutations associated with neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastase. Nat Genet 2003; 35:90-96.
90. Benson KF, Li FQ, Person RE, et al. The genetic and cellular basis of hereditary neutropenia: elastase or adaptin mutations disrupt their association and interfere with elastase's membrane and granule trafficking. Nat Genet 2003; 35:90-96.
91. Aprikyan AA, Kutyavin T, Stein S, et al. Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia. Exp Hematol 2003; 31:372-381.
92. Karsunky H, Zeng H, Schmidt T, et al. Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1. Nat Genet 2002; 30:295-300.
93. Taunton J, Rowning BA, Coughlin ML, et al. Actin-dependent propulsion of endosomes and lysosomes by recruitment of N-WASP. J Cell Biol 2000; 148:519-530.